Dr. Raymond A. Huml is the Vice President of Rare Disease Strategy at Sciensus, with over 30 years in the healthcare and biopharmaceutical industries. A leader in rare disease research and global due diligence, he has driven nearly $3 billion in capital commitments. A prolific author and award-winning expert, he is dedicated to advancing rare disease innovation, diversity, and global healthcare, including his Peace Corps service in Ghana.
Latest articles by Ray
View the latest articles written by Ray
Thought Leadership, Rare diseases
A strategic framework for global access and personalised care
Thought Leadership, Rare diseases
Pharmacists and specialty pharmacies in rare disease commercialisation
Thought Leadership, Rare diseases
Commercialization of rare & orphan products in Switzerland and smaller EU Markets